Can early-stage breast cancer be cured?
For patients with breast cancer, early diagnosis and timely, effective treatment can achieve a cure rate exceeding 80%; in some cases, the cure rate may reach as high as 95%, with long-term survivors living more than 20 years.
Breast cancer is relatively straightforward to diagnose. For patients with triple-positive breast cancer (i.e., estrogen receptor [ER]-positive, progesterone receptor [PR]-positive, and human epidermal growth factor receptor 2 [HER2]-positive), endocrine therapy is required following surgery. Additionally, adjuvant treatment regimens are selected based on lymph node metastasis status and immunohistochemical findings.
Following surgery, breast cancer patients require regular follow-up and monitoring—typically every six months—including chest CT, liver CT, breast and gynecological ultrasound examinations, and tumor marker testing. These assessments aim to detect potential metastatic lesions at an early stage; if necessary, further interventions such as surgery or intravenous chemotherapy may be warranted.